Porinju Veliyath Portfolio: Investor Earns Profits on Small Cap Pharmaceutical Stocks

Participation of Porinju Veliyath in Cupid

According to Cupid’s shareholding pattern for the period July to September 2022, the company name of Porinju Veliyath is missing while it was present in the company’s shareholding pattern for the period Q1FY22. In the company’s shareholding scheme for the first quarter of the current financial year, Porinju Veliyath owned 1.70 lakh shares in the company, or 1.27% of the company’s total paid-up capital.

This means that the founder of Equity Intelligence India either recorded profits on this small cap pharmaceutical stock or sold shares of the company to an extent that reduced his stake in the pharmaceutical company below 1% of the total paid-up capital of the company. company.

According to the stock exchange rule, it is mandatory for the listed company to share the names of each shareholder who owns 1% or more of the shares of the company. However, they are not required to share the details of buying and selling shares. It would therefore be difficult to determine whether the investor has sold his entire share in the business or whether he has reserved a partial profit in the business. But, it is certain that Czar of small cap stocks has recorded profits in this small cap pharmaceutical stock during the second quarter of the current financial year.

Cupid stock price history

Shares of the medical research company generated a moderate return for its position shareholders. Over the past six months, this small cap stock has lost nearly 15% while over the past year it has generated a 4% return for its investors. In fact, over the past year, it has given no return to its shareholders.